Celanese (CE)
(Delayed Data from NYSE)
$136.90 USD
+0.77 (0.57%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $136.96 +0.06 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Celanese Corporation [CE]
Reports for Purchase
Showing records 121 - 140 ( 474 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q21 Update - Outgrowing Tough Auto Market, Acetyls at Peak but Good LT Prospects
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q21 First Look - Overall Strong Earnings, but EM Surprises to Downside
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 3Q21 Preview - Sticking with Pricing Power
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 3Q21 Preview - Sticking with Pricing Power
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q21 Follow Up - EM Volumes and Margins Key in 2H21 as Acetyls Normalize
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
2Q21 First Look - Guidance Raise More Than Enough vs. Expectations, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 2Q21 Preview - Earnings Could Be a Positive Catalyst for the Sector, in Our View
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Santoprene Acquisition Additive to Value; Raising 2021 Estimates on Acetyls
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department